Boussard & Gavaudan Investment Management LLP : Form 8.3 -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
46
Boussard & Gavaudan Investment Management LLP : Form 8.3 - UBM PLC

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a)  Identity of the person whose positions/dealings are being disclosed: Boussard & Gavaudan Gestion  
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficient  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree   UBM Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e)  Date position held/dealing undertaken: 25 th May 2018
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? No

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   GBP 11.25p ordinary ISIN: JE00BD9WR069  
    Interests Short positions
Number % Number %
(1)  Relevant securities owned and/or controlled:      
(2)  Derivatives CFD (other than options):   9,382,065 2.380%    
(3)  Options and agreements to purchase/sell:    
  TOTAL: 9,382,065 2.380%    

All interests and all short positions should be disclosed.Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
 

 (b)       Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit GBP
GBP 11.25p ordinary CFD reducing a long position 13,423 1,013.00

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none"
     

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
     

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached ? NO
Date of disclosure:   28th May 2018
Contact name:   Deborah Gewinner
Telephone number:   +44 203 751 54 12

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Hit with Lawsuit Over Misleading Claims

Updated Category News Views 6

Unpacking Beta Bionics' Legal Storm Investors in Beta Bionics, Inc. —ticker BBNX—are probably feeling like they're caught in a whirlwind right now, and who can blame them? The company's facing a class action lawsuit, and the accusations aren't anything to sniff at. They're talking about violations of the Securities Exchange Act of 1934, along with some shady...

Continue Reading
Mountain Living: Facing the Population Growth Crunch

Updated Category News Views 0

Population Growth Reshaping U.S. Mountain Communities Living in a picturesque mountain town used to offer an idyllic escape from the hustle and bustle of city life. But now, even these scenic enclaves are feeling the squeeze from a wave of population growth that's hard to ignore. Mark Cromer tackles this head-on in his new Forum paper, 'The Long Goodnight of Rocky...

Continue Reading
Kenneth Spells: Championing Education Leadership in 2026

Updated Category News Views 3

Out there in Hoke County, you’ve got a man named Kenneth Spells shaking things up the way a strong leader should. Now, you know I’m not here to fluff up anyone’s feathers—especially in an arena as aching for reform as education. But credit where credit’s due, Spells picked up the ‘2026 Professional of the Year’ from The Inner Circle for a reason, and it’s...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 4

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
DICK'S Sporting Goods Faces Legal Challenges in Securities Suit

Updated Category News Views 4

Trouble Brewing at DICK'S Sporting Goods Wall Street's not only about the wins. There are moments when the market throws a curveball, and right now, DICK'S Sporting Goods is facing a fast one. DJS Law Group just laid out a class action lawsuit accusing them of bending the securities law rules. It ain't pretty when a company gets tangled up in legal battles, but it's...

Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth

Updated Category News Views 6

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Continue Reading
CAR T-Cell Therapy Offers New Hope for SPS Patients

Updated Category News Views 0

Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...

Continue Reading
Software Tax Hits Enterprises: Costly Control Concerns

Updated Category News Views 16

Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...

Continue Reading
Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Updated Category News Views 8

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Continue Reading
Tax Strategy Crucial: Sidnell & Webster of Lufkin Weigh In

Updated Category News Views 4

Breaking Down Tax Prep vs. Planning Ever wonder why some folks never break a sweat come tax season, while others scramble like their hair's on fire? It all boils down to understanding two very different animals: tax preparation and tax planning. CPA veterans Yvette Sidnell and Jennifer Webster over in Lufkin, Texas, have laid it out crystal clear in their article with...

Continue Reading

Top 5 Most Recently Viewed Articles

Rancho Mission Viejo: Leading the Way in Wellness Real Estate

Updated Category News Views 202

Rancho Mission Viejo Recognized Globally for Wellness Development The Ranch stands out as a model for wellness communities and showcases the impact on individual lives. This 23,000-acre master-planned community and functional cattle ranch has achieved global recognition as one of the largest intentional wellness real estate developments. A Testament to Community Design As...

Continue Reading
Revolutionizing Patient Access with AI: The New Trial Finder

Updated Category News Views 177

Introducing the Future of Clinical Trials The world of radiopharmaceuticals is changing rapidly, with an innovative new tool set to revolutionize the way patients and healthcare providers access critical information about clinical trials. The Radiopharmaceutical Trial Finder, backed by the ICPO Foundation, was developed through a collaboration between WARMTH and...

Continue Reading
Semler Scientific Faces Legal Challenges Amid Controversy

Updated Category News Views 157

Semler Scientific Under Legal Scrutiny Semler Scientific, Inc. is currently facing a class action lawsuit that sheds light on serious allegations regarding their securities practices. Shareholders of the company, identified by the ticker SMLR, are encouraged to be proactive amidst these developments. The lawsuit primarily alleges violations of federal securities exchanges...

Continue Reading
Charles Dayoub Joins The Willis Law Group Fraud Team

Updated Category News Views 207

Charles Dayoub Enhances The Willis Law Group’s Fraud Team We are delighted to announce that Charles Dayoub has joined The Willis Law Group P.L.L.C., bringing with him a wealth of experience with over 18 years in law and extensive expertise in executive positions. His previous role at a prominent law firm involved dealing with government receivables and regulatory...

Continue Reading
Evaluating Revolution Medicines' Future Potential and Progress

Updated Category News Views 168

Revolution Medicines Maintains Positive Outlook Piper Sandler has sustained an optimistic outlook regarding Revolution Medicines (NASDAQ: RVMD), reaffirming its Overweight rating with a specified price target of $57.00. This commitment to the stock's rating comes after recent developments linked to the company’s Phase I trial, which is focused on RMC-6236, a potential...

Continue Reading